PA
CNO icon

PharVision Advisers’s CNO Financial Group CNO Stock Holding History

PharVision Advisers’s Portfolio CNO Stock Details CNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,650
Closed -$210K – 312
2024
Q4 		$210K Buy
+5,650
New +$210K 0.18% 279

Other funds holding CNO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

PharVision Advisers's CNO Position: Q1 2025 in Review

PharVision Advisers sold out of CNO Financial Group (CNO) in Q1 2025, closing a stake of 5,650 shares — an estimated $210K sold.

PharVision Advisers first reported a position in CNO in Q4 2024 and held it in 1 quarter. The position peaked at $210K in Q4 2024. 343 funds tracked by Wall St. Rank hold CNO as of Q1 2025.

  • PharVision Advisers reported no remaining CNO Financial Group position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 5,650 CNO Financial Group shares in Q1 2025, an estimated $210K.
  • PharVision Advisers first reported a position in CNO Financial Group in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's CNO Financial Group position peaked at $210K in Q4 2024.
  • 343 funds tracked by Wall St. Rank held CNO Financial Group as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.